mPredict™ Co-Crystal Prediction Service

Poor solubility remains one of the biggest hurdles in drug development, with nearly 70% of APIs falling short in this area. The mPredict™ Co-crystal Prediction Service offers a faster, more efficient path to overcoming this challenge by using AI-powered computational chemistry to identify optimal co-formers for co-crystallization. This approach eliminates the need for extensive trial-and-error screening, saving time, reducing material use, and increasing the likelihood of successful formulation. The tool delivers a ranked list of co-former candidates within 3–5 days, and optional experimental validation services further confirm performance. With proven accuracy—validated by real-world testing—and a streamlined process that doesn’t require the drug substance for screening, this service empowers formulators to make confident, data-driven decisions.

Explore how you can accelerate formulation timelines and improve solubility outcomes.